These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Chemical adjuvants for plasmid DNA vaccines. Greenland JR, Letvin NL. Vaccine; 2007 May 10; 25(19):3731-41. PubMed ID: 17350735 [Abstract] [Full Text] [Related]
18. Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains. Ferrone CR, Perales MA, Goldberg SM, Somberg CJ, Hirschhorn-Cymerman D, Gregor PD, Turk MJ, Ramirez-Montagut T, Gold JS, Houghton AN, Wolchok JD. Clin Cancer Res; 2006 Sep 15; 12(18):5511-9. PubMed ID: 17000687 [Abstract] [Full Text] [Related]
19. Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma. Weber J, Boswell W, Smith J, Hersh E, Snively J, Diaz M, Miles S, Liu X, Obrocea M, Qiu Z, Bot A. J Immunother; 2008 Sep 15; 31(2):215-23. PubMed ID: 18481391 [Abstract] [Full Text] [Related]
20. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model. Rollman E, Mathy N, Bråve A, Boberg A, Kjerrström A, van Wely C, Engström G, Johansson S, Aperia K, Eriksson LE, Benthin R, Ertl P, Heeney J, Hinkula J, Voss G, Wahren B. Vaccine; 2007 Mar 01; 25(11):2145-54. PubMed ID: 17254672 [Abstract] [Full Text] [Related] Page: [Next] [New Search]